The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 24, 2026
Filed:
Feb. 28, 2022
Applicants:
Sbi Pharmaceuticals Co., Ltd., Tokyo, JP;
National Center for Child Health and Development, Tokyo, JP;
Inventors:
Assignees:
SBI Pharmaceuticals Co., Ltd., Tokyo, JP;
National Center for Child Health and Development, Tokyo, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/197 (2006.01); A61K 33/24 (2019.01); A61K 33/26 (2006.01); A61K 38/00 (2006.01); C07K 16/28 (2006.01); A61K 33/30 (2006.01);
U.S. Cl.
CPC ...
A61K 31/197 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); A61K 33/30 (2013.01); A61K 38/00 (2013.01);
Abstract
The object of the invention is to provide a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor. Provided is a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor comprising 5-aminolevulinic acids (ALAs) as the active ingredient.
Tanaka, Tohru. (2026). Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor (U.S. Patent No. 12558332). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12558332
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile